Rhythm Pharmaceuticals, Inc. Common Stock
Symbol: RYTM (NASDAQ)
100.49
▲ (0.21%) 0.215
Company Description:
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
Key Stats
- Today's Open: $100.485
- Today's High: $100.485
- Today's Low: $100.485
- Today's Volume: 142
- Yesterday Close: $100.27
- Yesterday High: $102.11
- Yesterday Low: $99.91
- Yesterday Volume: 520.25K
- Last Min Volume: 9
- Last Min High: $100.485
- Last Min Low: $100.485
- Last Min VWAP: $100.485
Company Profile
- Name: Rhythm Pharmaceuticals, Inc. Common Stock
- Website: https://www.rhythmtx.com
- Listed Date: 2017-10-05
- Location: BOSTON, MA
- Market Status: Active
- CIK Number: 0001649904
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $6.66B
- Round Lot: 100
- Outstanding Shares: 66.42M
- Asset Type: CS
RECENT FILINGS FOR RYTM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-25 | 4 | View |
| 2025-08-21 | 144 | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 4 | View |
| 2025-08-12 | 144 | View |
| 2025-08-12 | 144 | View |
| 2025-08-11 | 144 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-29 | 4 | View |
| 2025-07-11 | 4 | View |
| 2025-07-11 | 4 | View |
| 2025-07-11 | 4 | View |
| 2025-07-11 | 4 | View |
| 2025-07-11 | 8-K | View |
Latest News on RYTM